What Happens When the FDA Says, “I Don’t Know”

The FDA tries to track what are called “emerging safety signals.” In 2016, a study found a possible link between reduced leaflet mobility in TAVRs and the incidence of stroke in the fall. When people turned to the FDA looking for insight, the agency responded with, “Limited available data do not allow us to fully…